Nouryon Signs its First Power Purchase Agreement for an Onsite Solar Project in the US

Nouryon, a global specialty chemicals leader, announced today that it has signed a 30-year power purchase agreement (PPA) with Convergent Energy and Power to supply 2-megawatt (MW) of solar power to Nouryon’s manufacturing site in Morris, IL, US. The onsite solar field is expected to be operational in the second half of 2024.

Image Credit: Nouryon

“We are pleased to sign our first onsite PPA in the US as part of our commitment to reduce our greenhouse gas emissions,” said Eduardo Nardinelli, Senior Vice President, South America & Global Carbon Business Leader. “We view this agreement as another step towards increasing our renewable energy footprint.”

Nouryon aims to reduce its absolute Scopes 1 and 2 greenhouse gas emissions by 40% by 2030 compared to 2019 and aspires to be a net-zero organization by 2050. More information on the Company’s sustainability progress can be found in the full report, the ESG fact sheet and dedicated Sustainability section of the Company website.

Source: https://www.nouryon.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nouryon. (2023, May 26). Nouryon Signs its First Power Purchase Agreement for an Onsite Solar Project in the US. AZoCleantech. Retrieved on May 09, 2024 from https://www.azocleantech.com/news.aspx?newsID=33469.

  • MLA

    Nouryon. "Nouryon Signs its First Power Purchase Agreement for an Onsite Solar Project in the US". AZoCleantech. 09 May 2024. <https://www.azocleantech.com/news.aspx?newsID=33469>.

  • Chicago

    Nouryon. "Nouryon Signs its First Power Purchase Agreement for an Onsite Solar Project in the US". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=33469. (accessed May 09, 2024).

  • Harvard

    Nouryon. 2023. Nouryon Signs its First Power Purchase Agreement for an Onsite Solar Project in the US. AZoCleantech, viewed 09 May 2024, https://www.azocleantech.com/news.aspx?newsID=33469.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.